NeuroSpectrum Insights, Inc. (NSI) is a novel medical device company preparing to commercialize state-of-the-art technology that enhances a clinicians ability to identify various neurological and neurodevelopmental disorders, such as autism, dyslexia, attention-deficit/hyperactivity disorder (ADHD), and schizophrenia.
We seek medical, technological, and financing partners to research additional uses for our existing technology and for developing new technologies.
For more information on potential investing, collaborations, or partnerships please contact Andrew Stewart, CEO using the contact form below.
